Logo image of HTLM

HOMESTOLIFE LTD (HTLM) Stock Fundamental Analysis

NASDAQ:HTLM - Nasdaq - KYG458061093 - Common Stock - Currency: USD

3.69  -0.12 (-3.15%)

Fundamental Rating

2

HTLM gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 121 industry peers in the Specialty Retail industry. While HTLM seems to be doing ok healthwise, there are quite some concerns on its profitability. HTLM is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

HTLM had negative earnings in the past year.
HTLM had a negative operating cash flow in the past year.
HTLM Yearly Net Income VS EBIT VS OCF VS FCFHTLM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 1M -1M

1.2 Ratios

Looking at the Return On Assets, with a value of -19.33%, HTLM is doing worse than 85.12% of the companies in the same industry.
HTLM has a worse Return On Equity (-48.38%) than 71.90% of its industry peers.
Industry RankSector Rank
ROA -19.33%
ROE -48.38%
ROIC N/A
ROA(3y)-0.39%
ROA(5y)N/A
ROE(3y)9.06%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HTLM Yearly ROA, ROE, ROICHTLM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 20 -20 40 -40 60

1.3 Margins

HTLM has a better Gross Margin (65.82%) than 94.21% of its industry peers.
The Profit Margin and Operating Margin are not available for HTLM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HTLM Yearly Profit, Operating, Gross MarginsHTLM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 20 -20 40 -40 60

6

2. Health

2.1 Basic Checks

HTLM does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for HTLM has been increased compared to 1 year ago.
HTLM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
HTLM Yearly Shares OutstandingHTLM Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 5M 10M
HTLM Yearly Total Debt VS Total AssetsHTLM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

An Altman-Z score of 2.48 indicates that HTLM is not a great score, but indicates only limited risk for bankruptcy at the moment.
HTLM has a Altman-Z score (2.48) which is in line with its industry peers.
There is no outstanding debt for HTLM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.48
ROIC/WACCN/A
WACC9.81%
HTLM Yearly LT Debt VS Equity VS FCFHTLM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 1M -1M 2M 3M

2.3 Liquidity

A Current Ratio of 1.78 indicates that HTLM should not have too much problems paying its short term obligations.
HTLM has a Current ratio of 1.78. This is in the better half of the industry: HTLM outperforms 73.55% of its industry peers.
HTLM has a Quick Ratio of 1.57. This is a normal value and indicates that HTLM is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.57, HTLM belongs to the top of the industry, outperforming 85.12% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 1.57
HTLM Yearly Current Assets VS Current LiabilitesHTLM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 1M 2M 3M 4M 5M

0

3. Growth

3.1 Past

HTLM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -791.46%.
The Revenue for HTLM has decreased by -17.73% in the past year. This is quite bad
EPS 1Y (TTM)-791.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-763.72%
Revenue 1Y (TTM)-17.73%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-16.12%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HTLM Yearly Revenue VS EstimatesHTLM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 1M 2M 3M 4M 5M

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HTLM. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HTLM Price Earnings VS Forward Price EarningsHTLM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HTLM Per share dataHTLM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for HTLM!.
Industry RankSector Rank
Dividend Yield N/A

HOMESTOLIFE LTD

NASDAQ:HTLM (5/21/2025, 8:03:13 PM)

3.69

-0.12 (-3.15%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.28%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap54.21M
AnalystsN/A
Price TargetN/A
Short Float %0.95%
Short Ratio1.39
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 12.99
P/FCF N/A
P/OCF N/A
P/B 15.74
P/tB 15.74
EV/EBITDA N/A
EPS(TTM)-0.11
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0.28
BVpS0.23
TBVpS0.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -19.33%
ROE -48.38%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.82%
FCFM N/A
ROA(3y)-0.39%
ROA(5y)N/A
ROE(3y)9.06%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 8.24%
Cap/Sales 2.98%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 1.57
Altman-Z 2.48
F-Score3
WACC9.81%
ROIC/WACCN/A
Cap/Depr(3y)10.29%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.7%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-791.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-763.72%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-17.73%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-16.12%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-949.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-277.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-214.18%
OCF growth 3YN/A
OCF growth 5YN/A